Recent Company News

• 01:41 PM ET Dec 05, 2025
  

  StreetAccount Summary: Notable Drug Events expected for the week of 07-Dec

• 11:44 AM ET Nov 28, 2025
  

  StreetAccount Summary: Notable Drug Events expected for the week of 30-Nov

• 04:24 PM ET Nov 12, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 08:52 AM ET Nov 25, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 04:03 AM ET Nov 25, 2025
  

  In draft guidance, NICE recommends Autolus's AUCATZYL to treat r/r B-ALL ($1.24, 0.00)

• 02:17 PM ET Nov 12, 2025
  

  Transcript Intelligence: Autolus Therapeutics Q3 Earnings Guidance ($1.30, -0.20)

• 02:17 PM ET Nov 12, 2025
  

  Transcript Intelligence: Autolus Therapeutics Q3 Earnings Q&A ($1.29, -0.21)

• 02:17 PM ET Nov 12, 2025
  

  Transcript Intelligence: Autolus Therapeutics Q3 Earnings Themes ($1.30, -0.20)

• 09:17 AM ET Nov 12, 2025
  

  StreetAccount Summary - US Pre-market trading update